JUSTIN CRAWFORD: Open Payments
NPI 1871229757 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,904 in 47 payments from 7 companies in 2025. Trend: 2023 $583 · 2024 $1,044 · 2025 $3,904
Consulting: $2,060Food & beverage: $1,500Travel & lodging: $345
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $3,246 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $178 |
| Madrigal Pharmaceuticals | 6 | $176 |
| Intercept Pharmaceuticals, Inc. | 3 | $153 |
| Ipsen Biopharmaceuticals, Inc | 4 | $105 |
| Eton Pharmaceuticals, Inc. | 1 | $25 |
| ORPHALAN INC | 1 | $21 |
Products named: Livdelzi, XIFAXAN, REZDIFFRA, OCALIVA, IQIRVO, GALZIN, CUVRIOR.
Industry payments across TX — which companies pay providers there.
